Reactogenicity and Peak Anti-RBD-S1 IgG Concentrations in Individuals with No Prior COVID-19 Infection Vaccinated with Different SARS-CoV-2 Vaccines.

Milevoj Kopcinovic, Lara; Unic, Adriana; Nikolac Gabaj, Nora; Miler, Marijana; Vrtaric, Alen; Bozovic, Marija; Stefanovic, Mario

Milevoj Kopcinovic, Lara; Unic, Adriana; Nikolac Gabaj, Nora; Miler, Marijana; Vrtaric, Alen; Bozovic, Marija; Stefanovic, Mario.

Affiliation

Milevoj Kopcinovic L; Department of Clinical Chemistry, Sestre Milosrdnice University Hospital Center, Zagreb, Croatia.
Unic A; Department of Clinical Chemistry, Sestre Milosrdnice University Hospital Center, Zagreb, Croatia.
Nikolac Gabaj N; Department of Clinical Chemistry, Sestre Milosrdnice University Hospital Center, Zagreb, Croatia.
Miler M; Faculty of Pharmacy and Biochemistry, University of Zagreb, Zagreb, Croatia.
Vrtaric A; Department of Clinical Chemistry, Sestre Milosrdnice University Hospital Center, Zagreb, Croatia.
Bozovic M; Department of Clinical Chemistry, Sestre Milosrdnice University Hospital Center, Zagreb, Croatia.
Stefanovic M; Department of Clinical Chemistry, Sestre Milosrdnice University Hospital Center, Zagreb, Croatia.

Lab Med ; 55(2): 162-168, 2024 Mar 07.

Article de En | MEDLINE | ID: mdl-37294928

Sujet(s)
Mots clés

COVID vaccine; Comirnaty; SARS-CoV-2; Spikevax; Vaxzevria; anti-spike antibody; reactogenicity

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Immunoglobuline G / Immunogénicité des vaccins / Vaccins contre la COVID-19 / COVID-19 Type d'étude: Prognostic_studies Limites: Adult / Humans Langue: En Journal: Lab Med Année: 2024 Type de document: Article Pays d'affiliation: Croatie Pays de publication: Royaume-Uni

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google